Vanguard reports 8.3% stake in Research Inc
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 4,972,103 shares of Research Inc common stock, representing 8.3% of the class as of the event date of 12/31/2025.
Rhea-AI Filing Summary
The Vanguard Group filed an amended Schedule 13G reporting beneficial ownership of 4,972,103 shares of Research Inc common stock, representing 8.3% of the class as of the event date of 12/31/2025.
Vanguard reports no sole voting or dispositive power, with 408,800 shares subject to shared voting power and all 4,972,103 shares subject to shared dispositive power. Vanguard states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing also notes an internal realignment effective 01/12/2026, after which certain Vanguard subsidiaries are expected to report beneficial ownership separately while pursuing the same investment strategies.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake does The Vanguard Group report in ACMR (Research Inc)?
Why did The Vanguard Group amend its Schedule 13G for ACMR?
When did the ownership level triggering this ACMR filing occur?
AI-generated analysis. How Rhea-AI works. Not financial advice.